• Users Online: 476
  • Print this page
  • Email this page
CONCEPT AND ISSUE
Year : 2021  |  Volume : 22  |  Issue : 2  |  Page : 123-126

Mucormycosis in COVID-19 patients: A review


1 Tutor, College of nursing Government Medical College and Hospital, Chandigarh, India
2 Principal, College of nursing Government Medical College and Hospital, Chandigarh, India

Correspondence Address:
Mrs. Khina Sharma
Government Medical College and Hospital, Chandigarh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijcn.ijcn_87_21

Rights and Permissions

Mucormycosis is a rare but invasive, fungal infection mainly found in immunocompromised patients, which occurs due to the fungi mucormycetes. It is a rapidly occurring fungal infection with a high mortality rate. Although rare, the cases of mucormycosis have been raised abnormally in COVID-19 patients in India during second wave, in which a severe rise in COVID-19 cases was reported. Many states of India have already declared it as an epidemic, and the sad part is that the medication to treat it is running low. Mucormycosis has been reported in COVID-19-positive patients at any time after COVID-19 infection, either during hospitalisation or several days to weeks after discharge.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed580    
    Printed16    
    Emailed0    
    PDF Downloaded85    
    Comments [Add]    

Recommend this journal